Ingredion

INGRNYSEUSD

THESIS ALERT

Email me when the INGR thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$92.83
+$0.88 (+0.96%)Today 1M −3.30%
After hours$92.830.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$91.95
Prior regular-session close from the quote source.
$91.01–$92.83
Regular-session low and high so far today.
892.3K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$90.14–$123.49
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own INGR if value-added plant-based ingredient solutions keep lifting margins and cash flow despite a mature, commodity-linked revenue base.

INGR price history

Latest price$92.83Today+$0.88 (+0.96%)
INGR -3.69%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Ingredion’s exposure to food, beverage, animal nutrition, brewing and industrial uses should keep demand resilient across cycles, but the mature commodity-linked base means top-line growth needs calibration rather than being assumed.HoldingMateriality: High

    The company description says Ingredion provides ingredient solutions for food, beverage, animal nutrition, brewing and industrial markets. If the demand base stays resilient, shareholders can underwrite margin-led compounding; if customers reduce volumes or reformulate away, margin gains become harder to sustain.

    Watch: Large food and beverage customers reformulate away from corn-based sweeteners and starches toward alternative ingredients at scale.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The company description says Ingredion provides ingredient solutions for food, beverage, animal nutrition, brewing and industrial markets.

    Open source ↗
  • The core business can defend pricing and mix because customers buy Ingredion for value-added ingredient functionality, not only raw agricultural calories.StrengtheningMateriality: High

    The company description characterizes Ingredion as a global ingredient solutions provider that transforms plant-based materials into value-added ingredient solutions. If pricing and mix are durable, lower revenue can still produce higher earnings; if customers commoditize the offering, profitability reverts toward grain-processing economics.

    Watch: ADM, Cargill, Tate & Lyle or Roquette price aggressively in specialty starches, sweeteners or texturizers and force customers to rebid contracts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The company description characterizes Ingredion as a global ingredient solutions provider that transforms plant-based materials into value-added ingredient solutions.

    Open source ↗
  • Manufacturing scale and cost discipline should convert higher-value mix into operating leverage rather than letting logistics, plant costs and SG&A absorb the benefit.StrengtheningMateriality: Medium

    GAAP annual operating income rose from $762 million in FY2022 to $1.016 billion in FY2025. This determines whether the business is merely passing through input prices or actually compounding operating earnings.

    Watch: Plant utilization falls because customers shift volumes to competitors or regional suppliers, leaving fixed manufacturing costs underabsorbed.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income rose from $762 million in FY2022 to $1.016 billion in FY2025.

    Open source ↗
  • Working-capital discipline and cash conversion should let Ingredion self-fund reinvestment and shareholder value creation through commodity cycles without relying heavily on the balance sheet.HoldingMateriality: Medium

    GAAP annual operating cash flow was $944 million in FY2025, above GAAP net income of $729 million for the same period. If cash conversion holds, owners benefit from a more resilient compounder; if it fails, reported earnings may overstate economic value.

    Watch: Corn or other agricultural input inflation forces Ingredion to carry materially higher inventories and receivables before pricing is collected.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was $944 million in FY2025, above GAAP net income of $729 million for the same.

    Open source ↗
  • Balance-sheet capacity should give Ingredion flexibility to absorb agricultural cycles, invest in higher-value ingredients and return capital without becoming financially constrained.StrengtheningMateriality: Medium

    GAAP liabilities declined from $4.299 billion at FY2022 year-end to $3.531 billion at FY2025 year-end. Financial flexibility increases the chance that temporary commodity volatility does not become permanent equity dilution or forced retrenchment.

    Watch: Management pursues a large acquisition in specialty ingredients at a price that adds leverage without clear customer or cost synergies.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP liabilities declined from $4.299 billion at FY2022 year-end to $3.531 billion at FY2025 year-end.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Ingredion’s exposure to food, beverage, animal nutrition, brewing and industrial uses should keep demand resilient across cycles, but the mature commodity-linked base means top-line growth needs calibration rather than being assumed. If the demand base stays resilient, shareholders can underwrite margin-led compounding; if customers reduce volumes or reformulate away, margin gains become harder to sustain.

The core business can defend pricing and mix because customers buy Ingredion for value-added ingredient functionality, not only raw agricultural calories. If pricing and mix are durable, lower revenue can still produce higher earnings; if customers commoditize the offering, profitability reverts toward grain-processing economics.

Manufacturing scale and cost discipline should convert higher-value mix into operating leverage rather than letting logistics, plant costs and SG&A absorb the benefit. This determines whether the business is merely passing through input prices or actually compounding operating earnings.

Working-capital discipline and cash conversion should let Ingredion self-fund reinvestment and shareholder value creation through commodity cycles without relying heavily on the balance sheet. If cash conversion holds, owners benefit from a more resilient compounder; if it fails, reported earnings may overstate economic value.

Balance-sheet capacity should give Ingredion flexibility to absorb agricultural cycles, invest in higher-value ingredients and return capital without becoming financially constrained. Financial flexibility increases the chance that temporary commodity volatility does not become permanent equity dilution or forced retrenchment.

All standing thesis claims
Original report summary

value-added plant-based ingredient solutions keep lifting margins and cash flow despite a mature, commodity-linked revenue base.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Ingredion

Where the evidence on Ingredion stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Ingredion’s exposure to food, beverage, animal nutrition, brewing and industrial uses should keep demand resilient across cycles, but the mature commodity-linked base means top-line growth needs calibration rather than being assumed.

    sec.gov ↗

  • The core business can defend pricing and mix because customers buy Ingredion for value-added ingredient functionality, not only raw agricultural calories.

    sec.gov ↗

  • Manufacturing scale and cost discipline should convert higher-value mix into operating leverage rather than letting logistics, plant costs and SG&A absorb the benefit.

    sec.gov ↗

  • Working-capital discipline and cash conversion should let Ingredion self-fund reinvestment and shareholder value creation through commodity cycles without relying heavily on the balance sheet.

    sec.gov ↗

  • Balance-sheet capacity should give Ingredion flexibility to absorb agricultural cycles, invest in higher-value ingredients and return capital without becoming financially constrained.

    sec.gov ↗

Bear case: what would count against it

  • Large food and beverage customers reformulate away from corn-based sweeteners and starches toward alternative ingredients at scale.

    sec.gov ↗

  • ADM, Cargill, Tate & Lyle or Roquette price aggressively in specialty starches, sweeteners or texturizers and force customers to rebid contracts.

    sec.gov ↗

  • Plant utilization falls because customers shift volumes to competitors or regional suppliers, leaving fixed manufacturing costs underabsorbed.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Ingredion

Loading the break-condition record for Ingredion.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Ingredion filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Ingredion filed an SEC 8-K on 2026-08-20: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Ingredion filed an SEC 8-K on 2026-08-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large food and beverage customers reformulate away from corn-based sweeteners and starches toward alternative ingredients at scale.
  • ADM, Cargill, Tate & Lyle or Roquette price aggressively in specialty starches, sweeteners or texturizers and force customers to rebid contracts.
  • Plant utilization falls because customers shift volumes to competitors or regional suppliers, leaving fixed manufacturing costs underabsorbed.
  • Corn or other agricultural input inflation forces Ingredion to carry materially higher inventories and receivables before pricing is collected.
  • Management pursues a large acquisition in specialty ingredients at a price that adds leverage without clear customer or cost synergies.

INGR news

Loading headlines…

Financial statements

INGR income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

INGR: quick answers

What is INGR's short interest?
As of October 30, 2026, 4.6M INGR shares were sold short, 7.33% of its shares outstanding, down 2.4% from the count before. At the stock's average daily volume that is 6.4 days to cover. FINRA publishes the count twice a month. INGR short interest history
Have members of Congress traded INGR?
Reports made public in the last 90 days disclose 1 trade in INGR by 1 filer: 0 purchases and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed INGR trade
Which well-known investors own INGR?
1 of the 37 well-known funds tracked here reported INGR shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

INGR in well-known investors’ portfolios

1 of 37 funds reported INGR shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.04%$10.3M+49.7%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.